AOD-9401
Experimental Nootropic PeptideresearchAlso known as: AOD9401, Nootropic Peptide AOD-9401
An experimental nootropic peptide investigated for cognitive enhancement, neuroprotection, and memory improvement, derived from research into growth hormone fragments and neural signaling.
Overview
AOD-9401 is an experimental peptide that has gained attention in the nootropic and biohacking communities for its purported cognitive-enhancing properties. It is part of the broader family of bioactive peptide fragments being explored for neurological applications. While significantly less studied than established nootropic peptides like Semax or Selank, AOD-9401 is reported to enhance memory consolidation, improve focus and mental clarity, and provide neuroprotective effects. The evidence base remains largely preclinical and anecdotal, with no published human clinical trials. Users in the peptide community report improved cognitive performance, particularly in memory and processing speed, though rigorous scientific validation is lacking.
Mechanism of Action
The precise mechanism of AOD-9401 is not fully characterized, but proposed actions include: (1) Modulation of neurotrophic factor expression including BDNF; (2) Enhancement of cholinergic neurotransmission; (3) Potential interaction with growth factor signaling pathways in the CNS; (4) Neuroprotective effects through antioxidant pathway activation; (5) Possible modulation of synaptic plasticity and long-term potentiation.
Molecular Formula
Not fully published
Molecular Weight
Not fully published
Sequence
Proprietary/research sequence
Dosage Protocols
Dose Range
100mcg – 500mcg
Frequency
Once daily
Route
subcutaneous or intranasal
Cycle Length
4-8 weeks
No established clinical dosing. Community protocols vary widely. Some users report intranasal administration for faster CNS effects. Start at lowest dose to assess tolerance.
Source: Anecdotal community protocols
🧮 Personalized Dosage Calculator
💰 Estimated Pricing
Typical Supply
5mg vial
Last Updated
2026-02
Research peptide. Limited availability and data. Often confused with AOD-9604.
⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.
Side Effects
| Effect | Severity |
|---|---|
| Headache | mild |
| Insomnia | mild |
| Nasal irritation | mild |
| Unknown long-term effects | moderate |
Pros & Cons
Anecdotal reports of improved memory, focus, and cognitive clarity
Potential neuroprotective properties based on preclinical research
Can be administered intranasally for convenient, non-invasive dosing
Extremely limited published research — mostly anecdotal evidence
No human clinical trials to validate efficacy or safety
Molecular details and exact mechanism not fully published
Quality and purity concerns with research-grade sourcing
Research Studies
🩸 Blood Work
No specific bloodwork requirements reported for this peptide. General health panels are always recommended before starting any peptide protocol.
Legal Status
Research chemical only. Not approved by any regulatory agency. No human clinical trials published. Available from select research peptide suppliers. Regulatory status unclear in most jurisdictions.
Readers Also Viewed
Semaglutide
99An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
98A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
97A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
95The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Related Peptides
Semaglutide
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
CJC-1295 + Ipamorelin (Combo)
The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Collagen Peptides
Bioactive peptide fragments derived from hydrolyzed collagen protein that support skin elasticity, joint health, bone density, hair/nail growth, and gut lining integrity through stimulation of endogenous collagen synthesis.